Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels

William A. Catterall, Alan L. Goldin and Stephen G. Waxman
Pharmacological Reviews December 2005, 57 (4) 397-409; DOI: https://doi.org/10.1124/pr.57.4.4
William A. Catterall
Department of Pharmacology, University of Washington, Seattle, Washington (W.A.C.); Department of Microbiology and Molecular Genetics, University of California, Irvine, California (A.L.G.); and Department of Neurology, Yale University School of Medicine, New Haven, Connecticut (S.G.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan L. Goldin
Department of Pharmacology, University of Washington, Seattle, Washington (W.A.C.); Department of Microbiology and Molecular Genetics, University of California, Irvine, California (A.L.G.); and Department of Neurology, Yale University School of Medicine, New Haven, Connecticut (S.G.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen G. Waxman
Department of Pharmacology, University of Washington, Seattle, Washington (W.A.C.); Department of Microbiology and Molecular Genetics, University of California, Irvine, California (A.L.G.); and Department of Neurology, Yale University School of Medicine, New Haven, Connecticut (S.G.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The family of voltage-gated sodium channels initiates action potentials in all types of excitable cells. Nine members of the voltage-gated sodium channel family have been characterized in mammals, and a 10th member has been recognized as a related protein. These distinct sodium channels have similar structural and functional properties, but they initiate action potentials in different cell types and have distinct regulatory and pharmacological properties. This article presents the molecular relationships and physiological roles of these sodium channel proteins and provides comprehensive information on their molecular, genetic, physiological, and pharmacological properties.

Introduction

Voltage-gated sodium channels are responsible for action potential initiation and propagation in excitable cells, including nerve, muscle, and neuroendocrine cell types. They are also expressed at low levels in nonexcitable cells, where their physiological role is unclear. Sodium channels are the founding members of the ion channel superfamily in terms of their discovery as a protein and determination of their amino acid sequence. This article presents an introduction to their biochemical, molecular, and genetic properties, physiological roles, and pharmacological significance.

Sodium Channel Subunits

Sodium channels consist of a highly processed α subunit, which is approximately 260 kDa, associated with auxiliary β subunits (Catterall, 2000). Sodium channels in the adult central nervous system and heart contain β1 through β4 subunits, whereas sodium channels in adult skeletal muscle have only the β1 subunit (Isom, 2001). The pore-forming α subunit is sufficient for functional expression, but the kinetics and voltage dependence of channel gating are modified by the β subunits, and these auxiliary subunits are involved in channel localization and interaction with cell adhesion molecules, extracellular matrix, and intracellular cytoskeleton. The α subunits are organized in four homologous domains (I-IV), each of which contain six transmembrane α helices (S1-S6) and an additional pore loop located between the S5 and S6 segments (Fig. 1). The pore loops line the outer, narrow entry to the pore, whereas the S5 and S6 segments line the inner, wider exit from the pore. The S4 segments in each domain contain positively charged amino acid residues at every third position. These residues serve as gating charges and move across the membrane to initiate channel activation in response to depolarization of the membrane. The short intracellular loop connecting homologous domains III and IV serves as the inactivation gate, folding into the channel structure and blocking the pore from the inside during sustained depolarization of the membrane.

Sodium Channel Classification and Nomenclature

A variety of different sodium channels has been identified by electrophysiological recording, biochemical purification, and cloning (Goldin, 2001). The sodium channels are members of the superfamily of ion channels that includes voltage-gated potassium and calcium channels (Yu and Catterall, 2004); however, unlike the different classes of potassium and calcium channels, the functional properties of the known sodium channels are relatively similar. Despite their similarity of function, the sodium channels were originally named in many different ways, with no consistent nomenclature for the various isoforms. To eliminate confusion resulting from the multiplicity of names, a standardized nomenclature was developed for voltage-gated sodium channels (Goldin et al., 2000). This nomenclature is based on that for voltage-gated potassium channels (Chandy and Gutman, 1993). It uses a numerical system to define subfamilies and subtypes based on similarities between the amino acid sequences of the channels. A comparable nomenclature has also been adopted for voltage-gated calcium channels (Ertel et al., 2000; Catterall et al., 2005). In this nomenclature system, the name of an individual channel consists of the chemical symbol of the principal permeating ion (Na) with the principal physiological regulator (voltage) indicated as a subscript (NaV). The number following the subscript indicates the gene subfamily (currently only NaV1), and the number following the full point identifies the specific channel isoform (e.g., NaV1.1). This last number has been assigned according to the approximate order in which each gene was identified. Splice variants of each family member are identified by lowercase letters following the numbers (e.g., NaV1.1a).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Transmembrane organization of sodium channel subunits. The primary structures of the subunits of the voltage-gated ion channels are illustrated as transmembrane-folding diagrams. Cylinders represent probable α-helical segments. Bold lines represent the polypeptide chains of each subunit, with length approximately proportional to the number of amino acid residues in the brain sodium channel subtypes. The extracellular domains of the β1 and β2 subunits are shown as immunoglobulin-like folds. Ψ, sites of probable N-linked glycosylation; P, sites of demonstrated protein phosphorylation by protein kinase A (circles) and protein kinase C (diamonds); shaded, pore-lining S5-P-S6 segments; white circles, the outer (EEDD) and inner (DEKA) rings of amino residues that form the ion selectivity filter and tetrodotoxin binding site; ++, S4 voltage sensors; h in shaded circle, inactivation particle in the inactivation gate loop; open shaded circles, sites implicated in forming the inactivation gate receptor. Sites of binding of α- and β-scorpion toxins and a site of interaction between α and β1 subunits are also shown.

The nine mammalian sodium channel isoforms that have been identified and functionally expressed are all greater than 50% identical in amino acid sequence in the transmembrane and extracellular domains, where the amino acid sequence is similar enough for clear alignment (Fig. 2A). For potassium channels and calcium channels, all members of distinct subfamilies are less than 50% identical to those of other families, and there is much closer sequence similarity within families (Chandy and Gutman, 1993; Ertel et al., 2000). The sodium channel sequences vary more continuously, without defining separate families. By this criterion, all of the nine sodium channel isoforms may be considered members of one family.

Sodium Channel Genes

To test this hypothesis more critically, the nine sodium channel amino acid sequences were aligned and compared for relatedness using a maximum parsimony procedure that measured their evolutionary distance by calculating the number of nucleotide changes required for the change in codon at each position (Fig. 2B). The resulting phylogenetic tree is consistent with designation of these sodium channels as a single family. NaV1.1, NaV1.2, NaV1.3, and NaV1.7 are the most closely related group by this analysis. All four of these sodium channels are highly tetrodotoxin-sensitive and are broadly expressed in neurones. Their genes are all located on human chromosome 2q23-24, consistent with a common evolutionary origin. NaV1.5, NaV1.8, and NaV1.9 are also closely related (Fig. 2B), and their amino acid sequences are greater than 64% identical to those of the four sodium channels encoded on chromosome 2. These sodium channels are tetrodotoxin-resistant to varying degrees due to changes in amino acid sequence at a single position in domain I, and they are highly expressed in heart and dorsal root ganglion neurons (Fozzard and Hanck, 1996; Catterall, 2000). Their genes are located on human chromosome 3p21-24, consistent with a common evolutionary origin. The isoforms NaV1.4, expressed primarily in skeletal muscle, and NaV1.6, expressed primarily in the central nervous system, are set apart from these other two closely related groups of sodium channel genes (Fig. 2B). Although their amino acid sequences are greater than 84% identical to the group of sodium channels whose genes are located on chromosome 2 (Fig. 2A), their phylogenetic relationship is much more distant when analyzed by parsimony comparison (Fig. 2B). This distant evolutionary relationship is consistent with the location of the genes encoding these two sodium channels on chromosomes 17q23-25 and 12q13, respectively. The chromosome segments carrying the sodium channel genes are paralogous segments that contain many sets of related genes, including the homeobox gene clusters. These segments were generated by whole genome duplication events during early vertebrate evolution (Plummer and Meisler, 1999). The comparisons of amino acid sequence identity and phylogenetic and chromosomal relationships lead to the conclusion that all nine members of the sodium channel family that have been functionally expressed are members of a single family of proteins and have arisen from gene duplications and chromosomal rearrangements relatively recently in evolution. These results contrast with those for potassium channels and calcium channels, for which distinct gene families have arisen earlier in evolution and have been maintained as separate families to the present (Chandy and Gutman, 1993; Ertel et al., 2000).

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Amino acid sequence similarity and phylogenetic relationships of voltage-gated sodium channel α subunits. Phylogenetic relationships by maximum parsimony analysis of rat sodium channel sequences Nav1.1-Nav1.9 and Nax. To perform the analysis, the amino acid sequences for all isoforms were aligned using Clustal W. The amino acid sequences in the alignments were then replaced with the published nucleotide sequences, and the nucleotide sequence alignments were subjected to analysis using the program PAUP*. Divergent portions of the terminal regions and the cytoplasmic loops between domains I-II and II-III were excluded from the PAUP* analysis. The tree was rooted by including the invertebrate sodium channel sequences during the generation of the tree, although these sequences are not shown in the figure.

In addition to these nine sodium channels that have been functionally expressed, closely related sodium channel-like proteins have been cloned from mouse, rat, and human but have not yet been functionally expressed (Nax). They are approximately 50% identical to the NaV1 subfamily of channels but more than 80% identical to each other. They have significant amino acid sequence differences in the voltage sensors, inactivation gate, and pore region that are critical for channel function and have previously been proposed as a distinct subfamily (George et al., 1992). These atypical sodium channel-like proteins are expressed in heart, uterus, smooth muscle, astrocytes, and neurones in the hypothalamus and peripheral nervous system. Because of their sequence differences, it is possible that these channels are not highly sodium-selective or voltage-gated. Although these proteins have striking differences in amino acid sequence in highly conserved regions of sodium channels, their amino acid sequence is greater than 50% identical to other sodium channels. They are closely related phylogenetically to the group of sodium channels on human chromosome 2q23-24, where their gene is also located (Goldin et al., 2000). Successful functional expression of these atypical sodium channel-like proteins and identification of additionally related sodium channels may provide evidence for a second sodium channel subfamily.

Four auxiliary subunits of sodium channels have been defined thus far: NaVβ1, NaVβ2, NaVβ3, and NaVβ4 (Catterall, 2000; Isom, 2001; Yu et al., 2004). In the event that additional subunits are identified, we propose that the nomenclature should be comparable to that for the auxiliary subunits of calcium channels (Ertel et al., 2000).

Sodium Channel Molecular Pharmacology

All of the pharmacological agents that act on sodium channels have receptor sites on the α subunits. At least six distinct receptor sites for neurotoxins and one receptor site for local anesthetics and related drugs have been identified (Cestèle and Catterall, 2000; Table 1). Neurotoxin receptor site 1 binds the nonpeptide pore blockers tetrodotoxin and saxitoxin and the peptide pore blocker μ-conotoxin (Fozzard and Hanck, 1996; Terlau and Stühmer, 1998; Catterall, 2000). The receptor sites for these toxins are formed by amino acid residues in the pore loops and immediately on the extracellular side of the pore loops at the outer end of the pore. Neurotoxin receptor site 2 binds a family of lipid-soluble toxins, including batrachotoxin, veratridine, aconitine, and grayanotoxin, which enhance activation of sodium channels. Photoaffinity labeling and mutagenesis studies implicate transmembrane segments IS6 and IVS6 in the receptor site for batrachotoxin (Cestèle and Catterall, 2000). Neurotoxin receptor site 3 binds the α-scorpion toxins and sea anemone toxins, which slow the coupling of sodium channel activation to inactivation. These peptide toxins bind to a complex receptor site that includes the S3-S4 loop at the outer end of the S4 segment in domain IV (Cestèle and Catterall, 2000). Neurotoxin receptor site 4 binds the β-scorpion toxins, which enhance activation of the channels. The receptor site for the β-scorpion toxins includes the S3-S4 loop at the extracellular end of the voltage-sensing S4 segments in domain II (Cestèle and Catterall, 2000). Neurotoxin receptor site 5 binds the complex polyether toxins brevetoxin and ciguatoxin, which are made by dinoflagellates and cause toxic red tides in warm ocean waters (Cestèle and Catterall, 2000). Transmembrane segments IS6 and IVS5 are implicated in brevetoxin binding from photoaffinity labeling studies (Cestèle and Catterall, 2000). Neurotoxin receptor site 6 binds δ-conotoxins, which slow the rate of inactivation like the α-scorpion toxins. The location of neurotoxin receptor site 6 is unknown. Finally, the local anesthetics and related antiepileptic and antiarrhythmic drugs bind to overlapping receptor sites located in the inner cavity of the pore of the sodium channel (Catterall, 2000). Amino acid residues in the S6 segments from at least three of the four domains contribute to this complex drug receptor site, with the IVS6 segment playing the dominant role.

View this table:
  • View inline
  • View popup
TABLE 1

Receptor sites on sodium channels

Tables 2, 3, 4, 5, 6, 7, 8, 9, 10 summarize the major molecular, physiological, and pharmacological properties for each of the nine sodium channels that have been functionally expressed. Quantitative data are included for voltage dependence of activation and inactivation, single-channel conductance, and binding of drugs and neurotoxins, focusing on those agents that are widely used and diagnostic of channel identity and function.

View this table:
  • View inline
  • View popup
TABLE 2

NaV1.1 channels

View this table:
  • View inline
  • View popup
TABLE 3

NaV1.2 channels

View this table:
  • View inline
  • View popup
TABLE 4

NaV1.3 channels

View this table:
  • View inline
  • View popup
TABLE 5

NaV1.4 channels

View this table:
  • View inline
  • View popup
TABLE 6

NaV1.5 channels

View this table:
  • View inline
  • View popup
TABLE 7

NaV1.6 channels

View this table:
  • View inline
  • View popup
TABLE 8

NaV1.7 channels

View this table:
  • View inline
  • View popup
TABLE 9

NaV1.8 channels

View this table:
  • View inline
  • View popup
TABLE 10

NaV1.9 channels

Footnotes

  • The authors serve as the Subcommittee on Sodium Channels of the Nomenclature Committee of the International Union of Pharmacology.

  • Article, publication date, and citation information can be found at http://pharmrev.aspetjournals.org.

  • doi:10.1124/pr.57.4.4.

  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26: 13-25.
    OpenUrlCrossRefPubMed
  2. Caterall WA, Perez-Reyes E, Snitch TP, and Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57: 411-425.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Cestèle S and Catterall WA (2000) Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 82: 883-892.
    OpenUrlPubMed
  4. ↵
    Chandy KG and Gutman GA (1993) Nomenclature for mammalian potassium channel genes. Trends Pharmacol Sci 14: 434.
    OpenUrlCrossRefPubMed
  5. ↵
    Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, et al. (2000) Nomenclature of voltage-gated calcium channels. Neuron 25: 533-535.
    OpenUrlCrossRefPubMed
  6. ↵
    Fozzard HA and Hanck DA (1996) Structure and function of voltage-dependent sodium channels: Comparison of brain II and cardiac isoforms. Physiol Rev 76: 887-926.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    George AL Jr, Knittle TJ, and Tamkun MM (1992) Molecular cloning of an atypical voltage-gated sodium channel expressed in human heart and uterus: evidence for a distinct gene family. Proc Natl Acad Sci USA 89: 4893-4897.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Goldin AL (2001) Resurgence of sodium channel research. Annu Rev Physiol 63: 871-894.
    OpenUrlCrossRefPubMed
  9. ↵
    Goldin AL, Barchi RL, Caldwell JH, Hofmann F, Howe JR, Hunter JC, Kallen RG, Mandel G, Meisler MH, Berwald Netter Y, et al. (2000) Nomenclature of voltage-gated sodium channels. Neuron 28: 365-368.
    OpenUrlCrossRefPubMed
  10. ↵
    Isom LL (2001) Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7: 42-54.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Plummer NW and Meisler MH (1999) Evolution and diversity of mammalian sodium channel genes. Genomics 57: 323-331.
    OpenUrlCrossRefPubMed
  12. ↵
    Terlau H and Stühmer W (1998) Structure and function of voltage-gated ion channels. Naturwissenschaften 85: 437-444.
    OpenUrlCrossRefPubMed
  13. ↵
    Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, Ferriera H, Lilly J, DiStefano PS, Catterall WA, et al. (2004) Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci 23: 7577-7585.
    OpenUrl
  14. ↵
    Yu FH and Catterall WA (2004) The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Science STKE 253: re15.
    OpenUrl
PreviousNext
Back to top

In this issue

Pharmacological Reviews: 57 (4)
Pharmacological Reviews
Vol. 57, Issue 4
1 Dec 2005
  • Table of Contents
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels

William A. Catterall, Alan L. Goldin and Stephen G. Waxman
Pharmacological Reviews December 1, 2005, 57 (4) 397-409; DOI: https://doi.org/10.1124/pr.57.4.4

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherIUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels

William A. Catterall, Alan L. Goldin and Stephen G. Waxman
Pharmacological Reviews December 1, 2005, 57 (4) 397-409; DOI: https://doi.org/10.1124/pr.57.4.4
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Sodium Channel Subunits
    • Sodium Channel Classification and Nomenclature
    • Sodium Channel Genes
    • Sodium Channel Molecular Pharmacology
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • International Union of Pharmacology. LI. Nomenclature and Structure-Function Relationships of Cyclic Nucleotide-Regulated Channels
  • International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels
  • International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels
Show more IUPHAR Compendium of Voltage-Gated Ion Channels 2005

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics